Photo by lunarts from unsplash
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia. Nintedanib significantly reduced the annual rate of decline in forced vital capacity (FVC) compared with placebo… Click to show full abstract
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia. Nintedanib significantly reduced the annual rate of decline in forced vital capacity (FVC) compared with placebo in patients with IPF in two replicate trials (INPULSIS®). We examined the efficacy and safety of nintedanib in Japanese patients.
Keywords:
idiopathic pulmonary;
japanese patients;
pulmonary fibrosis;
inpulsis;
nintedanib japanese
Journal Title: Respirology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Respirology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!